Pompe Disease Registry
Status: | Recruiting |
---|---|
Conditions: | Endocrine, Diabetes |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | Any |
Updated: | 3/15/2019 |
Start Date: | August 21, 2004 |
End Date: | September 30, 2022 |
Contact: | Trial Transparency email recommended (Toll free number for US & Canada) |
Email: | Contact-Us@sanofi.com |
Phone: | 800-633-1610 |
The Pompe Registry is an ongoing, international multi-center, strictly observational program
that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of
treatment status. No experimental intervention is involved; patients in the Registry undergo
clinical assessments and receive care as determined by the patient's treating physician.
The objectives of the Registry are:
- To enhance the understanding of the variability, progression, and natural history of the
key manifestations of Pompe disease;
- To assist the Pompe medical community with the development of recommendations for
monitoring patients and reports on patient outcomes to help optimize patient care;
- To characterize and describe the Pompe disease population as a whole; and
- To evaluate the long-term effectiveness and safety of available treatment options
including ERT(Enzyme Replacement Therapy) with Myozyme®.
that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of
treatment status. No experimental intervention is involved; patients in the Registry undergo
clinical assessments and receive care as determined by the patient's treating physician.
The objectives of the Registry are:
- To enhance the understanding of the variability, progression, and natural history of the
key manifestations of Pompe disease;
- To assist the Pompe medical community with the development of recommendations for
monitoring patients and reports on patient outcomes to help optimize patient care;
- To characterize and describe the Pompe disease population as a whole; and
- To evaluate the long-term effectiveness and safety of available treatment options
including ERT(Enzyme Replacement Therapy) with Myozyme®.
Inclusion Criteria:
- Patient must have a confirmed diagnosis of Pompe disease, documented by
GAA(Glucosidase Alpha Acid) enzyme deficiency or GAA gene mutation
Exclusion Criteria:
- There are no exclusion criteria
We found this trial at
9
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials